Zimmer Partners’s Amgen AMGN Stock Holding History

Zimmer Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-18,000	Closed	-$5.8M	–	148
2024 Q3	$5.8M	Buy	+18,000	New	+$5.89M	0.11%	102

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Zimmer Partners's AMGN Position: Q4 2024 in Review

Zimmer Partners sold out of Amgen (AMGN) in Q4 2024, closing a stake of 18,000 shares — an estimated $5.8M sold.

Zimmer Partners first reported a position in AMGN in Q3 2024 and held it in 1 quarter. The position peaked at $5.8M in Q3 2024. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

Zimmer Partners reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
Zimmer Partners sold 18,000 Amgen shares in Q4 2024, an estimated $5.8M.
Zimmer Partners first reported a position in Amgen in Q3 2024 and held it in 1 quarter.
Zimmer Partners's Amgen position peaked at $5.8M in Q3 2024.
2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Zimmer Partners's 13F filing for Q4 2024, filed 14 Feb 2025.